Product Recalls in Indiana

Product recalls affecting Indiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Indiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,747 recalls have been distributed to Indiana in the last 12 months.

53,528 total recalls
2,747 in last 12 months

Showing 47614780 of 13,412 recalls

DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Arginine Hydrochloride Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension Recalled by...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: MIC-B12 Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: MIC-PLEX Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Methylprednisolone Acetate Injectable Suspension Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Methylprednisolone Acetate Injectable Suspension Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Triamcinolone Diacetate Injectable Suspension Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Methylcobalamin Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Nicotinamide Adenine Dinucleotide (PF) Injection Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Polyoxyl Lauryl Ether (Polidocanol) Injection Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension Recalled by...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Selenium Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: AscorbiX (Buffered C) Injection Recalled by Fusion IV Pharmaceuticals, Inc....

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2020· Hikma Pharmaceuticals USA Inc.

Recalled Item: methylPREDNISolone Sodium Succinate For Injection Recalled by Hikma...

The Issue: Labeling: Incorrect Instructions: Vial label incorrectly instructs...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 14, 2020· Pharmaceutical Associates Inc

Recalled Item: Nystatin Oral Suspension Recalled by Pharmaceutical Associates Inc Due to...

The Issue: Subpotent: Out of specification for assay at the 12-month time point.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2020· Advanced Accelerator Applications USA, Inc.

Recalled Item: NETSPOT Recalled by Advanced Accelerator Applications USA, Inc. Due to...

The Issue: Defective Container: loose aluminum cap crimp for the dilution buffer vial...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 10, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets Recalled by Lupin...

The Issue: CGMP Deviations: Out of specification test result observed during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 10, 2020· PD-Rx Pharmaceuticals, Inc.

Recalled Item: ranitidine hydrochloride Recalled by PD-Rx Pharmaceuticals, Inc. Due to CGMP...

The Issue: CGMP Deviations: Received notice from supplier of potential...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 7, 2020· Preferred Pharmaceuticals, Inc

Recalled Item: Preferred Pharmaceuticals Recalled by Preferred Pharmaceuticals, Inc Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund